Illegitimate WNT Signaling Promotes Proliferation of Multiple Myeloma Cells
Patrick W. B. Derksen, Tjin, Esther, Meijer, Helen P., Klok, Melanie D., Harold D. Mac Gillavry, Marinus H. J. van Oers, Lokhorst, Henk M., Bloem, Andries C., Clevers, Hans, Nusse, Roel, van der Neut, Ronald, Spaargaren, Marcel, Pals, Steven T., Weissman, Irving L.
Published in Proceedings of the National Academy of Sciences - PNAS (20.04.2004)
Published in Proceedings of the National Academy of Sciences - PNAS (20.04.2004)
Get full text
Journal Article
Extremely high levels of von Willebrand factor antigen and of procoagulant factor VIII found in multiple myeloma patients are associated with activity status but not with thalidomide treatment
Minnema, M. C., Fijnheer, R., De Groot, P. G., Lokhorst, H. M.
Published in Journal of thrombosis and haemostasis (01.03.2003)
Published in Journal of thrombosis and haemostasis (01.03.2003)
Get full text
Journal Article
Clinical efficacy of daratumumab monotherapy in patients with heavily pretreated relapsed or refractory multiple myeloma
Usmani, Saad Z., Weiss, Brendan M., Plesner, Torben, Bahlis, Nizar J., Belch, Andrew, Lonial, Sagar, Lokhorst, Henk M., Voorhees, Peter M., Richardson, Paul G., Chari, Ajai, Sasser, A.Kate, Axel, Amy, Feng, Huaibao, Uhlar, Clarissa M., Wang, Jianping, Khan, Imran, Ahmadi, Tahamtan, Nahi, Hareth
Published in Blood (07.07.2016)
Published in Blood (07.07.2016)
Get full text
Journal Article
Joint HOVON-50/GMMG-HD3 randomized trial on the effect of thalidomide as part of a high-dose therapy regimen and as maintenance treatment for newly diagnosed myeloma patients
GOLDSCHMIDT, H, SONNEVELD, P, HOELZER, D, HO, A. D, LOKHORST, H. M, CREMER, F. W, VAN DER HOLT, B, WESTVEER, P, BREITKREUTZ, I, BENNER, A, GLASMACHER, A, SCHMIDT-WOLF, I. G. D, MARTIN, H
Published in Annals of hematology (01.10.2003)
Published in Annals of hematology (01.10.2003)
Get full text
Journal Article
Natural history of relapsed myeloma, refractory to immunomodulatory drugs and proteasome inhibitors: a multicenter IMWG study
Kumar, S K, Dimopoulos, M A, Kastritis, E, Terpos, E, Nahi, H, Goldschmidt, H, Hillengass, J, Leleu, X, Beksac, M, Alsina, M, Oriol, A, Cavo, M, Ocio, E M, Mateos, M V, O'Donnell, E K, Vij, R, Lokhorst, H M, van de Donk, N W C J, Min, C, Mark, T, Turesson, I, Hansson, M, Ludwig, H, Jagannath, S, Delforge, M, Kyriakou, C, Hari, P, Mellqvist, U, Usmani, S Z, Dytfeld, D, Badros, A Z, Moreau, P, Kim, K, Otero, P R, Lee, J H, Shustik, C, Waller, D, Chng, W J, Ozaki, S, Lee, J-J, de la Rubia, J, Eom, H S, Rosinol, L, Lahuerta, J J, Sureda, A, Kim, J S, Durie, B G M
Published in Leukemia (01.11.2017)
Published in Leukemia (01.11.2017)
Get full text
Journal Article
Bortezomib before and after high-dose therapy in myeloma: long-term results from the phase III HOVON-65/GMMG-HD4 trial
Goldschmidt, H, Lokhorst, H M, Mai, E K, van der Holt, B, Blau, I W, Zweegman, S, Weisel, K C, Vellenga, E, Pfreundschuh, M, Kersten, M J, Scheid, C, Croockewit, S, Raymakers, R, Hose, D, Potamianou, A, Jauch, A, Hillengass, J, Stevens-Kroef, M, Raab, M S, Broijl, A, Lindemann, H W, Bos, G M J, Brossart, P, van Marwijk Kooy, M, Ypma, P, Duehrsen, U, Schaafsma, R M, Bertsch, U, Hielscher, T, Jarari, Le, Salwender, H J, Sonneveld, P
Published in Leukemia (01.02.2018)
Published in Leukemia (01.02.2018)
Get full text
Journal Article
Feasibility of controlling CD38-CAR T cell activity with a Tet-on inducible CAR design
Drent, Esther, Poels, Renée, Mulders, Manon J, van de Donk, Niels W C J, Themeli, Maria, Lokhorst, Henk M, Mutis, Tuna
Published in PloS one (30.05.2018)
Published in PloS one (30.05.2018)
Get full text
Journal Article
Clinical Implications of Complex Pharmacokinetics for Daratumumab Dose Regimen in Patients With Relapsed/Refractory Multiple Myeloma
Xu, XS, Yan, X, Puchalski, T, Lonial, S, Lokhorst, HM, Voorhees, PM, Plesner, T, Liu, K, Khan, I, Jansson, R, Ahmadi, T, Ruixo, JJ Perez, Zhou, H, Clemens, PL
Published in Clinical pharmacology and therapeutics (01.06.2017)
Published in Clinical pharmacology and therapeutics (01.06.2017)
Get full text
Journal Article
Mechanisms of peripheral neuropathy associated with bortezomib and vincristine in patients with newly diagnosed multiple myeloma: a prospective analysis of data from the HOVON-65/GMMG-HD4 trial
Broyl, Annemiek, Dr, Corthals, Sophie L, MSc, Jongen, Joost LM, MD, van der Holt, Bronno, PhD, Kuiper, Rowan, BSc, de Knegt, Yvonne, BSc, van Duin, Mark, PhD, el Jarari, Laila, MSc, Bertsch, Uta, MD, Lokhorst, Henk M, Prof, Durie, Brian G, MD, Goldschmidt, Hartmut, Prof, Sonneveld, Pieter, Prof
Published in The lancet oncology (01.11.2010)
Published in The lancet oncology (01.11.2010)
Get full text
Journal Article
Phase 1/2 study of lenalidomide combined with low-dose cyclophosphamide and prednisone in lenalidomide-refractory multiple myeloma
Nijhof, Inger S., Franssen, Laurens E., Levin, Mark-David, Bos, Gerard M.J., Broijl, Annemiek, Klein, Saskia K., Koene, Harry R., Bloem, Andries C., Beeker, Aart, Faber, Laura M., van der Spek, Ellen, Ypma, Paula F., Raymakers, Reinier, van Spronsen, Dick-Johan, Westerweel, Peter E., Oostvogels, Rimke, van Velzen, Jeroen, van Kessel, Berris, Mutis, Tuna, Sonneveld, Pieter, Zweegman, Sonja, Lokhorst, Henk M., van de Donk, Niels W.C.J.
Published in Blood (10.11.2016)
Published in Blood (10.11.2016)
Get full text
Journal Article
CD44 variant isoforms are involved in plasma cell adhesion to bone marrow stromal cells
VAN DRIEL, M, GÜNTHERT, U, VAN KESSEL, A. C, JOLING, P, STAUDER, R, LOKHORST, H. M, BLOEM, A. C
Published in Leukemia (2002)
Published in Leukemia (2002)
Get full text
Journal Article
Genetic Factors Underlying the Risk of Thalidomide-Related Neuropathy in Patients With Multiple Myeloma
JOHNSON, David C, CORTHALS, Sophie L, VAN NESS, Brian, CHILD, J. Anthony, SONNEVELD, Pieter, MORGAN, Gareth J, WALKER, Brian A, ROSS, Fiona M, GREGORY, Walter M, DICKENS, Nicholas J, LOKHORST, Henk M, GOLDSCHMIDT, Hartmut, DAVIES, Faith E, DURIE, Brian G. M
Published in Journal of clinical oncology (01.03.2011)
Published in Journal of clinical oncology (01.03.2011)
Get full text
Journal Article
Safety and Efficacy of Daratumumab Monotherapy in Patients with Heavily Pretreated Relapsed and Refractory Multiple Myeloma: Final Results from GEN501 and Sirius
Usmani, Saad Z, Nahi, Hareth, Weiss, Brendan M, Bahlis, Nizar J., Belch, Andrew, Lokhorst, Henk M, Voorhees, Peter M., Richardson, Paul G, Uhlar, Clarissa, Wang, Jianping, Qi, Ming, Lonial, Sagar
Published in BLOOD (08.12.2017)
Published in BLOOD (08.12.2017)
Get full text
Journal Article
Conference Proceeding
Subcutaneous Delivery of Daratumumab in Patients (pts) with Relapsed or Refractory Multiple Myeloma (RRMM): Pavo, an Open-Label, Multicenter, Dose Escalation Phase 1b Study
Chari, Ajai, Nahi, Hareth, Mateos, Maria-Victoria, Lokhorst, Henk M., Kaufman, Jonathan L., Moreau, Philippe, Oriol, Albert, Plesner, Torben, Benboubker, Lotfi, Hellemans, Peter, Masterson, Tara, Clemens, Pamela L, Liu, Kevin, San-Miguel, Jesus F., Usmani, Saad Z
Published in BLOOD (08.12.2017)
Published in BLOOD (08.12.2017)
Get full text
Journal Article
Conference Proceeding
Open-Label, Multicenter, Dose Escalation Phase 1b Study to Assess the Subcutaneous Delivery of Daratumumab in Patients (pts) with Relapsed or Refractory Multiple Myeloma (PAVO)
Usmani, Saad Z, Nahi, Hareth, Mateos, Maria-Victoria, Lokhorst, Henk M., Chari, Ajai, Kaufman, Jonathan L., Moreau, Philippe, Oriol, Albert, Plesner, Torben, Benboubker, Lotfi, Hellemans, Peter, Masterson, Tara, Clemens, Pamela L, Ahmadi, Tahamtan, Liu, Kevin, San-Miguel, Jesús
Published in BLOOD (02.12.2016)
Published in BLOOD (02.12.2016)
Get full text
Journal Article
Conference Proceeding
A Predictive Score for Early Mortality during Induction Therapy in Newly Diagnosed Transplant-Eligible Multiple Myeloma - an Analysis from Five GMMG and HOVON Multicenter Phase III Trials
Mai, Elias K, Hielscher, Thomas, Bertsch, Uta, Schlenzka, Jana, Salwender, Hans Jürgen, Lokhorst, Henk M, Munder, Markus, van der Holt, Bronno, Gerecke, Christian, Pfreundschuh, Michael, Duhrsen, Ulrich, Brossart, Peter, Zweegman, Sonja, Neben, Kai, Hillengass, Jens, Raab, Marc-Steffen S, Hose, Dirk, Vellenga, Edo, Merz, Maximilian, Breitkreutz, Iris, Jauch, Anna, Kersten, Marie José, Martin, Hans, Lindemann, Hans-Walter, Peter, Norma, Croockewit, Sandra, Blau, Igor Wolfgang, Scheid, Christof, Weisel, Katja C., Sonneveld, Pieter, Goldschmidt, Hartmut
Published in Blood (08.12.2017)
Published in Blood (08.12.2017)
Get full text
Journal Article
The occurrence of graft-versus-host disease is the major predictive factor for response to donor lymphocyte infusions in multiple myeloma
Lokhorst, Henk M., Wu, Kalung, Verdonck, Leo F., Laterveer, Laurens L., van de Donk, Niels W.C.J., van Oers, Marinus H.J., Cornelissen, Jan J., Schattenberg, Anton V.
Published in Blood (01.06.2004)
Published in Blood (01.06.2004)
Get full text
Journal Article
Reduced relapse rate in upfront tandem autologous/reduced-intensity allogeneic transplantation in multiple myeloma only results in borderline non-significant prolongation of progression-free but not overall survival
Lokhorst, Henk M, van der Holt, Bronno, Cornelissen, Jan J, Kersten, Marie José, van Oers, Marinus, Raymakers, Reinier, Minnema, Monique C, Zweegman, Sonja, Bos, Gerard, Schaap, Nicolaas, Wittebol, Shulamiet, de Weerdt, Okke, Ammerlaan, Rianne, Sonneveld, Pieter
Published in Haematologica (Roma) (01.12.2015)
Published in Haematologica (Roma) (01.12.2015)
Get full text
Journal Article
Thalidomide before and after autologous stem cell transplantation in recently diagnosed multiple myeloma (HOVON-50): long-term results from the phase 3, randomised controlled trial
van de Donk, Niels Wcj, van der Holt, Bronno, Minnema, Monique C, Vellenga, Edo, Croockewit, Sandra, Kersten, Marie José, von dem Borne, Peter A, Ypma, Paula, Schaafsma, Ron, de Weerdt, Okke, Klein, Saskia K, Delforge, Michel, Levin, Mark-David, Bos, Gerard M, Jie, Kon-Siong G, Sinnige, Harm, Coenen, Jules Llm, de Waal, Esther G, Zweegman, Sonja, Sonneveld, Pieter, Lokhorst, Henk M
Published in The Lancet. Haematology (01.10.2018)
Published in The Lancet. Haematology (01.10.2018)
Get more information
Journal Article